Keep yourself up to date
Seattle, WA, April 1 2019. Cyrus Biotechnology is proud to announce a major step forward in computer biochemistry, the ROSVAC-4, an industrial-strength minicomputer custom-designed for simulations of biological molecules, with an astonishingly small 1900 sq ft. footprint, capable of over 10 simultaneous protein amino acid sequence calculations per annum, improving on ROSVAC-2 at 5 calculations […]
March 26, 2019 SEATTLE, March 26, 2019 — Cyrus Biotechnology, Inc., a biotechnology software company offering advanced protein modeling and design tools to the Biopharmaceutical, Synthetic Biology, Chemical, and Consumer Products industries is pleased to announce its participation in the 15th Annual PEGS Boston Protein Engineering Summit in Boston, from April 8th through April 11th. […]
SEATTLE, WA March 11, 2019 — Cyrus Biotechnology, Inc., a Seattle-based biotech software company commercializing the advanced protein design platform Rosetta announced today that Dr Yifan Song, Cyrus Bio Chief Scientific Officer, will speak at an upcoming meeting of the Boston Area Group for Informatics and Modeling (BAGIM). Topic: Got Structure? State-of-the-art protein structure prediction […]
SEATTLE, WA March 5, 2019 — Cyrus Biotechnology, Inc., a Seattle-based biotech software company commercializing Rosetta, an advanced protein design platform, announced today the release of a novel Antibody Structure Prediction Software tool as part of its Cyrus Bench® platform. “Antibodies make up the majority of Biologics, and now Cyrus users can model new antibodies […]
Seattle, WA, January 7, 2019 – Cyrus Biotechnology, Inc., a Seattle-based firm offering access to Rosetta, the most advanced and validated software available for protein modeling and accelerated drug discovery, announced today the general release of an improved tool to predict the effect of sequence mutations on protein stability. This new software allows Cyrus customers […]